Jabra Enhance Select 300 vs MDHearing Volt

The Jabra Enhance Select 300 is a premium OTC hearing aid priced at $1,695 that earns an A grade with a SoundScore of 4.1/5 in our lab testing. This behind-the-ear device ranks #17 among 65 OTC hearing aids tested, placing it in the top 25% of its category. In our testing, the Enhance Select 300 demonstrates notable strengths in speech clarity for quiet environments, scoring 0.85 points above the OTC category average. Feedback handling is excellent at 5.0/5, and own-voice comfort scores a solid 3.5/5—nearly a full point above average for the category. Music streaming performance, while above average for OTC devices, remains mixed in absolute terms at 2.6/5. The device's main limitation appears in challenging listening environments. Speech-in-noise performance scored 1.5/5, which is low in absolute terms and essentially matches the category average. Users who frequently encounter noisy restaurants, busy offices, or crowded gatherings may find this a meaningful constraint. The Enhance Select 300 is best suited for individuals who primarily need improved hearing in quieter settings such as home conversations, one-on-one meetings, or watching television. It offers reliable streaming to both iPhone and Android devices, rechargeable batteries, and hands-free functionality. Shoppers seeking stronger noise performance at this price point may want to compare alternatives like the Lucid Tala or Audicus Omni 2, which scored higher overall in our testing.

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.